Advanced non-small cell lung cancer Trials in New York, United States
Conditions / Advanced non-small cell lung cancer / New York, United States
Clinical trials for Advanced non-small cell lung cancer investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02108964 | A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies | COMPLETED | PHASE1/PHASE2 |
| NCT05318573 | A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT04032847 | ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC | TERMINATED | PHASE1/PHASE2 |
| NCT03516981 | A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495) | COMPLETED | PHASE2 |
| NCT02143466 | AZD9291 in Combination With Ascending Doses of Novel Therapeutics | ACTIVE_NOT_RECRUITING | — |
| NCT03681483 | RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer | COMPLETED | PHASE1 |
| NCT07185997 | Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations | RECRUITING | — |
| NCT00633789 | Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types | COMPLETED | PHASE2 |
| NCT05557591 | A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT05652868 | Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer | TERMINATED | PHASE1 |